SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from CareCloud, Inc. (CCLD, CCLDO) (CIK 0001582982) (CCLD) — Jun 20, 2017

CareCloud, Inc. (CCLD, CCLDO) (CIK 0001582982)
Date: June 20, 2017 · CIK: 0001582982 · Accession: 0001493152-17-006914

AI Filing Summary & Sentiment

File numbers found in text: 333-214863

Date
June 14, 2017
Author
SONG P.C.
Form
CORRESP
Company
CareCloud, Inc. (CCLD, CCLDO) (CIK 0001582982)

Letter

June 20, 2017

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

F. Street, N.E.

Washington, DC 20549

Attn:

Ms. Jan Woo

Ms. Ji Shin

Re: Medical Transcription Billing, Corp.

Amendment No. 3 to Registration Statement on Form S-1

Submitted June 14, 2017

File No.: 333-214863

Ladies and Gentlemen:

On behalf of Medical Transcription Billing, Corp., a Delaware corporation (the “Company”), we respectfully submit the following responses to the comments received from the staff (the “Staff”) of the Securities and Exchange Commission by telephone on June 16, 2017 with respect to the above referenced registration statement (the “Registration Statement”). We have filed through EDGAR Amendment No. 4 to the Registration Statement. For the Staff’s reference, we have also forwarded copies of Amendment No. 4 marked to show changes from Amendment No. 3 to the Registration Statement. A copy of this letter has been furnished on EDGAR as correspondence.

In this letter, we have summarized in bold face type the comments you conveyed to us. The Company’s response to each comment is set forth immediately below the text of the applicable comment.

We understand that you will be reviewing the Company’s responses and may have additional comments. We welcome any questions you may have concerning the Company’s responses and thank you for your attention devoted to the filing.

MTBC/Form S-1 (No. 333-214863) Page 2 of 2

June 20, 2017

Staff Comments and Company Responses:

1. Please remove the “Total” column from the offering price table on the prospectus cover page.

Response: The Company has revised the prospectus cover page by removing the Total column from the offering price table.

2. Please correct the Form 8-K filing date referenced in the Montgomery Coscia Greilich LLP consent from November 30, 2016 to December 1, 2016.

Response: The Company has filed an amended consent from Montgomery Coscia Greilich LLP to reference the Form 8-K filed on December 1, 2016.

Thank you in advance for your review. Please contact me with any questions or comments you may have at (212) 599-3077.

Very
truly yours,
MAZZEO
SONG P.C.

Show Raw Text
CORRESP
1
filename1.htm

June
20, 2017

VIA
EDGAR

Securities
and Exchange Commission

Division
of Corporation Finance

100
F. Street, N.E.

Washington,
DC 20549

    Attn:

    Ms.
    Jan Woo

    Ms.
    Ji Shin

    Re:
    Medical
    Transcription Billing, Corp.

    Amendment
    No. 3 to Registration Statement on Form S-1

    Submitted
    June 14, 2017

    File
    No.: 333-214863

Ladies
and Gentlemen:

On
behalf of Medical Transcription Billing, Corp., a Delaware corporation (the “Company”), we respectfully submit the
following responses to the comments received from the staff (the “Staff”) of the Securities and Exchange Commission
by telephone on June 16, 2017 with respect to the above referenced registration statement (the “Registration Statement”).
We have filed through EDGAR Amendment No. 4 to the Registration Statement. For the Staff’s reference, we have also forwarded
copies of Amendment No. 4 marked to show changes from Amendment No. 3 to the Registration Statement. A copy of this letter has
been furnished on EDGAR as correspondence.

In
this letter, we have summarized in bold face type the comments you conveyed to us. The Company’s response to each comment
is set forth immediately below the text of the applicable comment.

We
understand that you will be reviewing the Company’s responses and may have additional comments. We welcome any questions
you may have concerning the Company’s responses and thank you for your attention devoted to the filing.

    MTBC/Form
    S-1 (No. 333-214863)
    Page
    2 of 2

    June
    20, 2017

Staff
Comments and Company Responses:

    1.
    Please
    remove the “Total” column from the offering price table on the prospectus cover page.

    Response:
    The Company has revised the prospectus cover page by removing the Total column from the offering price table.

    2.
    Please
    correct the Form 8-K filing date referenced in the Montgomery Coscia Greilich LLP consent from November 30, 2016 to December
    1, 2016.

    Response:
    The Company has filed an amended consent from Montgomery Coscia Greilich LLP to reference the Form 8-K filed on December 1,
    2016.

Thank
you in advance for your review. Please contact me with any questions or comments you may have at (212) 599-3077.

    Very
    truly yours,

    MAZZEO
    SONG P.C.

    /s/
    David S. Song

    David
    S. Song

    Partner

    cc:
    Mr.
    Mahmud Haq, Medical Transcription Billing, Corp.

    Mr.
    Stephen Snyder, Medical Transcription Billing, Corp.

    Mr.
    Bill Korn, Medical Transcription Billing, Corp.

    Ms.
    Shruti Patel, Medical Transcription Billing, Corp.